Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective
Saved in:
| Published in: | Degenerative Neurological and Neuromuscular Disease |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: (Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective
- A Hypothesized Therapeutic Role of (Z)-Endoxifen in Duchenne Muscular Dystrophy (DMD)
- Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies
- Gut Microbiome–Sleep Crosstalk: Mechanistic Pathways, Dysbiosis Signatures, and Microbiome‐Based Interventions
- Intellectual and behavioural functioning in boys with Duchenne Muscular Dystrophy : neuropsychological testing and correlation with genotype
- We need to explain subjective experience, but its explanation may not be mechanistic
- Cistanche deserticola Stem Extract Attenuates Depression Through NF-κB Pathway Modulation: Insights from Network Pharmacology and Experimental Validation